Trending News

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

Supreme Court Eliminates Heightened Discrimination Standard Under Title VII

Cleaning the Cupboard—Six More Decisions in One Day, and a Largely Harmonious Court - SCOTUS Today

U.S. Supreme Court Holds Majority-Group Plaintiffs Are Not Subject to a Heightened Evidentiary Standard Under Title VII

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Senti Bio Participates in Nasdaq Amplify Spotlight Series
Posted On Monday, June 30, 2025
INVO Fertility Adds Platelet-Rich Plasma Therapy Capabilities at Wisconsin Fertility Institute
Posted On Monday, June 30, 2025
Windtree Announces Istaroxime Phase 2 Cardiogenic Shock Study Hits Enrollment Target for Planned Interim Analysis
Posted On Monday, June 30, 2025
Accredited Investors: Navigating the Post-Pandemic Landscape
Posted On Monday, June 30, 2025
Ashvattha Therapeutics Presents Positive Interim Phase 2 Results for Subcutaneous Migaldendranib Treatment for DME and Wet-AMD at 2025 MaculArt Meeting
Posted On Monday, June 30, 2025
Clene Provides Regulatory Update Following Constructive FDA Type-C Meeting on Neurofilament Biomarker Analysis Plan and Confirms Two Additional FDA Meetings
Posted On Monday, June 30, 2025
Revolution Medicines and Summit Therapeutics Enter into Clinical Collaboration to Evaluate Combinations of Three RAS(ON) Inhibitors with Ivonescimab in RAS Mutant Tumors
Posted On Monday, June 30, 2025
Tectonic Therapeutic Joins Russell 3000® Index
Posted On Monday, June 30, 2025
Eyenovia Adds $10 Million in HYPE to its Treasury Holdings in Preparation for Strategic Onchain Engagement
Posted On Monday, June 30, 2025
Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China
Posted On Monday, June 30, 2025
LogicFlo raises $2.7M to arm every life sciences expert with their own AI workforce
Posted On Monday, June 30, 2025
Chemomab Announces Oral Presentation of Positive Nebokitug Phase 2 Clinical Data in Primary Sclerosing Cholangitis at BSG Live’25
Posted On Monday, June 30, 2025
23andMe Receives Court Approval for Sale to TTAM Research Institute, a Nonprofit Public Benefit Corporation
Posted On Monday, June 30, 2025
Corbus Pharmaceuticals Initiates Multiple Ascending Dose Portion of Phase 1 Study of Highly Peripherally Restricted CB1 Inverse Agonist CRB-913 for the Treatment of Obesity
Posted On Monday, June 30, 2025
Spectral AI Announces Submission to FDA of its DeepView® System
Posted On Monday, June 30, 2025
Cidara Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes
Posted On Monday, June 30, 2025
Tilde Sciences Announces Availability Of VECAMYL™ (Mecamylamine) With Exclusive Distribution Through Optime Care Specialty Pharmacy
Posted On Monday, June 30, 2025
Rakovina Therapeutics Highlights Strong H1 Progress and Unveils Strategic Priorities for H2 2025
Posted On Monday, June 30, 2025
Flower Expo Returns to Michigan and Illinois This Summer Following Blockbuster Northeast Event
Posted On Friday, June 27, 2025
Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock
Posted On Friday, June 27, 2025
Pliant Therapeutics Provides Update on BEACON-IPF
Posted On Friday, June 27, 2025
RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening
Posted On Friday, June 27, 2025
New Data for Nusinersen Underscore Biogen’s Commitment to Advancing Clinical Research to Improve Outcomes in SMA
Posted On Friday, June 27, 2025
Results of Annual General Meeting
Posted On Friday, June 27, 2025
Calidi Biotherapeutics Announces Shareholder Letter from CEO
Posted On Friday, June 27, 2025

Print